Diagnosis and Treatment of Drug-Resistant Tuberculosis

Arch Bronconeumol. 2017 Sep;53(9):501-509. doi: 10.1016/j.arbres.2017.02.006. Epub 2017 Mar 27.
[Article in English, Spanish]

Abstract

In the last 2 decades, drug-resistant tuberculosis has become a threat and a challenge to worldwide public health. The diagnosis and treatment of these forms of tuberculosis are much more complex and prognosis clearly worsens as the resistance pattern intensifies. Nevertheless, it is important to remember that with the appropriatesystematic clinical management, most of these patients can be cured. These guidelines itemize the basis for the diagnosis and treatment of all tuberculosis patients, from those infected by strains that are sensitive to all drugs, to those who are extensively drug-resistant. Specific recommendations are given forall cases. The current and future role of new molecular methods for detecting resistance, shorter multi-drug-resistant tuberculosis regimens, and new drugs with activity against Mycobacterium tuberculosis are also addressed.

Keywords: Diagnosis; Diagnóstico; Drug-resistant tuberculosis; Extremely drug-resistant tuberculosis; Multi-drug-resistant tuberculosis; Tratamiento; Treatment; Tuberculosis; Tuberculosis con resistencia a fármacos; Tuberculosis multi-drogorresistente.

MeSH terms

  • Antitubercular Agents / classification
  • Antitubercular Agents / pharmacology
  • Antitubercular Agents / therapeutic use*
  • Contact Tracing
  • Disease Management
  • Drug Therapy, Combination
  • Extensively Drug-Resistant Tuberculosis / diagnosis
  • Extensively Drug-Resistant Tuberculosis / drug therapy
  • Genotyping Techniques
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / genetics
  • Practice Guidelines as Topic
  • Tuberculosis, Multidrug-Resistant / diagnosis*
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / epidemiology

Substances

  • Antitubercular Agents